Urinary phthalate metabolites and the risk of endometrial polyp: A pilot study from the TREE cohort.

Phthalates, as endocrine disrupting chemicals that can alter the endogenous hormones, may be involved in the incidence of endometrial polyp, a benign hormone-dependent condition. We conducted a pilot case-control study from the Tongji Reproductive and Environmental (TREE) cohort to investigate the associations between phthalate exposures and the risk of endometrial polyp. A total of 40 endometrial polyp patients were matched to 80 controls by age and body mass index in the ratio of 1:2. Two spot urine samples from each subject were quantified for eight phthalate metabolites to enhance exposure assessment. The conditional logistic regression and quantile-based g-computation models were separately used to explore the associations between individual and mixture of urinary phthalate metabolites and the risk of endometrial polyp. After adjusting for covariates, individual chemical analyses showed that urinary monobenzyl phthalate (MBzP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono(2-ethylhexyl) phthalate (MEHHP) and the sum of di(2-ethylhexyl) phthalate (ΣDEHP) were associated with increased risks of endometrial polyp, with adjusted odds ratios ranging from 2.62 (95% CI: 0.88, 7.84) for MECPP to 6.96 (95% CI: 1.87, 25.87) for ΣDEHP comparing the extreme exposure categories (all P for trends <0.05 or = 0.057). These associations still persisted when these exposures were modeled as continuous variables. Chemical mixture analyses showed that a simultaneous one-quartile increase in concentrations of eight phthalate metabolites was associated with an elevated odds ratio of 3.14 (95% CI: 1.49, 6.60) in endometrial polyp. Our data suggest that exposure to individual benzylbutyl phthalate (BBzP) and DEHP, as well as mixture of phthalates is associated with increased risk of endometrial polyp. This may inform public health recommendations and policies to avoid phthalate exposures for improving female reproductive health.

[1]  K. Luo,et al.  Exposure to phthalates, phenols, and parabens mixture and alterations in sex steroid hormones among adolescents. , 2022, Chemosphere.

[2]  S. Swan,et al.  Prenatal Phthalate Exposure and Child Weight and Adiposity from in Utero to 6 Years of Age , 2022, Environmental health perspectives.

[3]  Q. Zeng,et al.  Associations between urinary bisphenol A and its analogues and semen quality: A cross-sectional study among Chinese men from an infertility clinic. , 2022, Environment international.

[4]  Q. Zeng,et al.  Exposure to disinfection by-products and reproductive hormones among women: Results from the Tongji Reproductive and Environmental (TREE) study. , 2022, Environmental research.

[5]  Q. Zeng,et al.  Associations between drinking water disinfection byproducts and menstrual cycle characteristics: A cross-sectional study among women attending an infertility clinic. , 2022, International journal of hygiene and environmental health.

[6]  Ying Guo,et al.  Phthalate metabolites: Characterization, toxicities, global distribution, and exposure assessment. , 2021, Environmental pollution.

[7]  Yuqing Zhang,et al.  Combined Exposure to Multiple Endocrine Disruptors and Uterine Leiomyomata and Endometriosis in US Women , 2021, Frontiers in Endocrinology.

[8]  M. Zhang,et al.  Urinary biomarkers of exposure to drinking water disinfection byproducts and ovarian reserve: A cross-sectional study in China. , 2021, Journal of hazardous materials.

[9]  I. Al-Saleh.  The relationship between urinary phthalate metabolites and polycystic ovary syndrome in women undergoing in vitro fertilization: Nested case-control study. , 2021, Chemosphere.

[10]  I. Ruscito,et al.  Effects of Endocrine-Disrupting Chemicals on Endometrial Receptivity and Embryo Implantation: A Systematic Review of 34 Mouse Model Studies , 2021, International journal of environmental research and public health.

[11]  A. Calafat,et al.  Maternal phthalate and phthalate alternative metabolites and urinary biomarkers of estrogens and testosterones across pregnancy. , 2021, Environment international.

[12]  J. Flaws,et al.  Urinary phthalate metabolite concentrations and serum hormone levels in pre- and perimenopausal women from the Midlife Women's Health Study. , 2021, Environment international.

[13]  E. Ha,et al.  The Association of Ovarian Reserve with Exposure to Bisphenol A and Phthalate in Reproductive-aged Women , 2020, Journal of Korean medical science.

[14]  Paige L. Williams,et al.  Incidence of uterine leiomyoma in relation to urinary concentrations of phthalate and phthalate alternative biomarkers: A prospective ultrasound study. , 2020, Environment international.

[15]  A. Covaci,et al.  Between- and within-individual variability of urinary phthalate and alternative plasticizer metabolites in spot, morning void and 24-hour pooled urine samples. , 2020, Environmental research.

[16]  R. Slama,et al.  Endocrine-disrupting chemicals: implications for human health. , 2020, The lancet. Diabetes & endocrinology.

[17]  S. Lindheim,et al.  Removal of uterine polyps: clinical management and surgical approach , 2020, Climacteric : the journal of the International Menopause Society.

[18]  Paige L. Williams,et al.  Urinary Concentrations of Phthalate Metabolite Mixtures in Relation to Serum Biomarkers of Thyroid Function and Autoimmunity among Women from a Fertility Center , 2020, Environmental health perspectives.

[19]  Q. Zeng,et al.  Phthalate metabolites and biomarkers of oxidative stress in the follicular fluid of women undergoing in vitro fertilization. , 2020, The Science of the total environment.

[20]  Kyungho Choi,et al.  Associations of exposure to phthalates and environmental phenols with gynecological disorders. , 2020, Reproductive toxicology.

[21]  Y. Cheon.  Di-(2-ethylhexyl) Phthalate (DEHP) and Uterine Histological Characteristics , 2020, Development & reproduction.

[22]  J. Flaws,et al.  Prenatal Exposure to a Phthalate Mixture Leads to Multigenerational and Transgenerational Effects on Uterine Morphology and Function in Mice. , 2020, Reproductive toxicology.

[23]  Alexander P Keil,et al.  A Quantile-Based g-Computation Approach to Addressing the Effects of Exposure Mixtures , 2019, Environmental health perspectives.

[24]  Fangfang Wang,et al.  The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization , 2019, The Journal of international medical research.

[25]  Y. Cheon,et al.  Chronic and Low Dose Exposure to Nonlyphenol or Di(2-Ethylhexyl) Phthalate Alters Cell Proliferation and the Localization of Steroid Hormone Receptors in Uterine Endometria in Mice , 2019, Development & reproduction.

[26]  R. Markham,et al.  Endometrial polyps: Pathogenesis, sequelae and treatment , 2019, SAGE open medicine.

[27]  M. Munro.  Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity. , 2019, Fertility and sterility.

[28]  A. Baccarelli,et al.  Phthalates exposure and uterine fibroid burden among women undergoing surgical treatment for fibroids: a preliminary study. , 2019, Fertility and sterility.

[29]  J. González,et al.  Variability of urinary concentrations of non-persistent chemicals in pregnant women and school-aged children. , 2018, Environment international.

[30]  M. Munro,et al.  The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[31]  J. Flaws,et al.  Di (2-ethylhexyl) phthalate (DEHP) alters proliferation and uterine gland numbers in the uteri of adult exposed mice. , 2018, Reproductive toxicology.

[32]  J. Brock,et al.  Prevalence and predictors of phthalate exposure in pregnant women in Charleston, SC. , 2018, Chemosphere.

[33]  N. Kamimura,et al.  Phthalates impact human health: Epidemiological evidences and plausible mechanism of action. , 2017, Journal of hazardous materials.

[34]  A. Seidel,et al.  Agonistic and antagonistic effects of phthalates and their urinary metabolites on the steroid hormone receptors ERα, ERβ, and AR. , 2017, Toxicology letters.

[35]  Chia-Yi Hsu,et al.  Benzyl butyl phthalate decreases myogenic differentiation of endometrial mesenchymal stem/stromal cells through miR-137-mediated regulation of PITX2 , 2017, Scientific Reports.

[36]  M. Widschwendter,et al.  The natural history of endometrial polyps , 2017, Human reproduction.

[37]  Maciej Liskiewicz,et al.  Robust causal inference using Directed Acyclic Graphs: the R package , 2018 .

[38]  Bo Chen,et al.  Phthalate monoesters in association with uterine leiomyomata in Shanghai , 2016, International journal of environmental health research.

[39]  Rémy Slama,et al.  Within-subject Pooling of Biological Samples to Reduce Exposure Misclassification in Biomarker-based Studies , 2016, Epidemiology.

[40]  S. Dong,et al.  The Inflammation Response to DEHP through PPARγ in Endometrial Cells , 2016, International journal of environmental research and public health.

[41]  S. Chun,et al.  Possible Role of Phthalate in the Pathogenesis of Endometriosis: In Vitro, Animal, and Human Data. , 2015, The Journal of clinical endocrinology and metabolism.

[42]  Yang Sun,et al.  Phthalate exposure and human semen quality: Results from an infertility clinic in China. , 2015, Environmental research.

[43]  J. Flaws,et al.  The Effects of Phthalates on the Ovary , 2015, Front. Endocrinol..

[44]  H. Taylor,et al.  The Role of Hox Genes in Female Reproductive Tract Development, Adult Function, and Fertility. , 2015, Cold Spring Harbor perspectives in medicine.

[45]  A. Calafat,et al.  Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study , 2014, BMC Endocrine Disorders.

[46]  Xueping Chen,et al.  Toxicity and Estrogenic Endocrine Disrupting Activity of Phthalates and Their Mixtures , 2014, International journal of environmental research and public health.

[47]  M. Thompson,et al.  Phthalates and risk of endometriosis. , 2013, Environmental Research.

[48]  Letian Zhao,et al.  Effects of DEHP on endometrial receptivity and embryo implantation in pregnant mice. , 2012, Journal of hazardous materials.

[49]  J. Abbott,et al.  Diagnosis and management of endometrial polyps: a critical review of the literature. , 2011, Journal of minimally invasive gynecology.

[50]  Chung-Hoon Kim,et al.  Increased viability of endometrial cells by in vitro treatment with di-(2-ethylhexyl) phthalate. , 2010, Fertility and sterility.

[51]  J. Weuve,et al.  Association of Exposure to Phthalates with Endometriosis and Uterine Leiomyomata: Findings from NHANES, 1999–2004 , 2010, Environmental health perspectives.

[52]  Eva Cecilie Bonefeld-Jorgensen,et al.  Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions. , 2009, Toxicology letters.

[53]  F. Hu,et al.  Passive Smoking and Risk of Peripheral Arterial Disease and Ischemic Stroke in Chinese Women Who Never Smoked , 2008, Circulation.

[54]  P. Vercellini,et al.  The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. , 1997, Human reproduction.

[55]  C. A. Harris,et al.  The estrogenic activity of phthalate esters in vitro. , 1997, Environmental health perspectives.